Purebase Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Purebase Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Nov 30, 2018 | $564.3K | Mar 15, 2019 |
| FY2018 | Nov 30, 2017 | $484.7K | Mar 15, 2019 |
| FY2017 | Nov 30, 2016 | $177.7K | Feb 28, 2018 |
| FY2016 | Nov 30, 2015 | $51.9K | Apr 12, 2017 |
| FY2015 | Nov 30, 2014 | $0 | Mar 14, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $285.4K | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | $310.5K | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | $325.9K | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $471.6K | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $369.5K | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $169.4K | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | $361.9K | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | $564.3K | Feb 28, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $212.5K | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | $229.8K | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | $229.7K | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $339.4K | Feb 28, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($2.28M) | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | ($1.48M) | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | ($9.09M) | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | ($32.58M) | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | ($8.31M) | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | ($1.51M) | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | ($3.13M) | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | ($1.16M) | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | ($1.63M) | Mar 15, 2019 |
| FY2017 | Nov 30, 2016 | ($2.70M) | Feb 28, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($1.48M) | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | ($1.38M) | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | ($8.70M) | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | ($32.54M) | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | ($8.24M) | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | ($1.54M) | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | ($1.35M) | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | ($1.10M) | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | ($2.14M) | Mar 15, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.61M | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | $1.58M | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | $1.54M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $1.26M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $8.50M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $1.43M | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | $1.50M | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | $1.45M | Feb 28, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($1.11M) | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | ($2.17M) | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | ($1.12M) | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | ($838.3K) | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | ($823.6K) | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | ($1.27M) | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | ($550.9K) | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | ($780.0K) | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | ($776.4K) | Mar 15, 2019 |
| FY2017 | Nov 30, 2016 | ($1.03M) | Feb 28, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2024 | $1.5K | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | $130.7K | Feb 28, 2025 |
| FY2018 | Nov 30, 2018 | $0 | Mar 15, 2019 |
| FY2018 | Nov 30, 2017 | $7.0K | Mar 15, 2019 |
| FY2014 | Nov 30, 2013 | $60.2K | Mar 16, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $224.7K | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | $797.0K | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | $811.5K | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $723.4K | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $774.5K | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $635.3K | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | $231.2K | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | $227.4K | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $286.1K | Mar 15, 2019 |
| FY2017 | Nov 30, 2016 | $947.5K | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.15M | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | $1.79M | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | $3.04M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $1.30M | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $2.96M | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $1.94M | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | $976.8K | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | $5.22M | Feb 28, 2020 |
| FY2015 | Nov 30, 2015 | $1.39M | Mar 14, 2016 |
| FY2015 | Nov 30, 2014 | $1.31M | Mar 14, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($929.0K) | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | ($991.4K) | Mar 18, 2026 |
| FY2025 | Nov 30, 2023 | ($2.23M) | Mar 18, 2026 |
| FY2024 | Nov 30, 2022 | ($572.5K) | Feb 28, 2025 |
| FY2023 | Nov 30, 2021 | ($2.19M) | Feb 28, 2024 |
| FY2022 | Nov 30, 2020 | ($1.30M) | Feb 28, 2023 |
| FY2021 | Nov 30, 2019 | ($745.6K) | Mar 15, 2022 |
| FY2020 | Nov 30, 2018 | ($4.99M) | Mar 16, 2021 |
| FY2019 | Nov 30, 2017 | ($4.03M) | Feb 28, 2020 |
| FY2017 | Nov 30, 2016 | ($2.79M) | Feb 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($66.49M) | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | ($64.21M) | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | ($62.73M) | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | ($53.64M) | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | ($21.06M) | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | ($12.75M) | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | ($11.25M) | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | ($8.12M) | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | ($6.95M) | Mar 15, 2019 |
| FY2017 | Nov 30, 2016 | ($5.32M) | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $5.3K | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | $28.1K | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | $5.6K | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | $19.1K | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | $132.3K | Feb 28, 2023 |
| FY2021 | Nov 30, 2020 | $7.5K | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | $8.4K | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | $8.3K | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | $6.3K | Mar 15, 2019 |
| FY2017 | Nov 30, 2016 | $555.6K | Feb 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Nov 30, 2015 | $0 | Mar 14, 2016 |
| FY2015 | Nov 30, 2014 | $1.00M | Mar 14, 2016 |
| FY2014 | Nov 30, 2013 | $679.8K | Mar 16, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | 0 | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | 0 | Feb 28, 2024 |
| FY2022 | Nov 30, 2021 | 0 | Feb 28, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | 0 | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | 0 | Feb 28, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 279.47M | Mar 18, 2026 |
| FY2025 | Nov 30, 2024 | 250.45M | Mar 18, 2026 |
| FY2024 | Nov 30, 2023 | 230.86M | Feb 28, 2025 |
| FY2023 | Nov 30, 2022 | 230.75M | Feb 28, 2024 |
| FY2023 | Nov 30, 2021 | 215.38M | Feb 28, 2024 |
| FY2021 | Nov 30, 2020 | 214.95M | Mar 15, 2022 |
| FY2020 | Nov 30, 2019 | 208.65M | Mar 16, 2021 |
| FY2019 | Nov 30, 2018 | 141.35M | Feb 28, 2020 |
| FY2018 | Nov 30, 2017 | 141.35M | Mar 15, 2019 |
| FY2017 | Nov 30, 2016 | 141.35M | Feb 28, 2018 |